UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21 : Different roles of G1 cyclins in cell proliferation and prognosis

Cancer research (Chicago, Ill.), 2001-03, Vol.61 (6), p.2500-2504

2001

Volltextzugriff (PDF)

CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non‐small cell lung cancers

Cancer science, 2003-11, Vol.94 (11), p.1003-1009

2003

Volltextzugriff (PDF)

Prognostic factors for non-small cell lung cancer patients with driver mutation negative and brain metastases (HOT 1701)

Annals of oncology, 2019-10, Vol.30, p.v650-v651

2019

Volltextzugriff (PDF)

1579P - Prognostic factors for non-small cell lung cancer patients with driver mutation negative and brain metastases (HOT 1701)

Annals of oncology, 2019-10, Vol.30, p.v650-v651

2019

Volltextzugriff (PDF)

1579PPrognostic factors for non-small cell lung cancer patients with driver mutation negative and brain metastases (HOT 1701)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Direct instillation of the fibrin glue into the ruptured bulla is an effective treatment for uncontrolled pneumothorax occurred from severe emphysematous bullae

Kyobu geka. The Japanese journal of thoracic surgery, 2011-04, Vol.64 (4), p.286

2011

Volltextzugriff (PDF)

Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome

British Journal of Cancer, 1999-06, Vol.80 (8), p.1289-1295

1999

Volltextzugriff (PDF)

Predictive value of expression of p16 , retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers

British Journal of Cancer, 1999-10, Vol.81 (4), p.696-701

1999

Volltextzugriff (PDF)

Cyclin A Is a c-Jun Target Gene and Is Necessary for c-Jun-induced Anchorage-independent Growth in RAT1a Cells

The Journal of biological chemistry, 2005-04, Vol.280 (17), p.16728-16738

2005

Volltextzugriff (PDF)

Phase II Study of Amrubicin (AMR) for Patients with Non-Small Cell Lung Cancer (NSCLC) as Third-Line or Fourth-Line Chemotherapy: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901

Annals of oncology, 2012-10, Vol.23, p.xi113

2012

Volltextzugriff (PDF)

Increased expression of β‐catenin predicts better prognosis in nonsmall cell lung carcinomas

Cancer, 2002-02, Vol.94 (3), p.752-758

2002

Volltextzugriff (PDF)

HMG-I/Y Is a c-Jun/Activator Protein-1 Target Gene and Is Necessary for c-Jun–Induced Anchorage-Independent Growth in Rat1a Cells

Molecular cancer research, 2004-05, Vol.2 (5), p.305-314

2004

Volltextzugriff (PDF)

Cyclin E Expression, a Potential Prognostic Marker for Non-Small Cell Lung Cancers

Clinical cancer research, 2000-01, Vol.6 (1), p.11-16

2000

Volltextzugriff (PDF)

Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers

Cancer research (Chicago, Ill.), 1998-01, Vol.58 (2), p.322-327

1998

Volltextzugriff (PDF)

Randomized, phase II trial comparing amrubicin with topotecan in patients (pts) with previously treated small cell lung cancer (SCLC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8042-8042

2008

Volltextzugriff (PDF)

Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8 super(+) cytotoxic T lymphocytes and natural killer cells

Cancer Immunology, Immunotherapy, 2008-02, Vol.57 (2), p.165-174

2008

Volltextzugriff (PDF)

RCAS1 Expression: A Potential Prognostic Marker for Adenocarcinomas of the Lung

Oncology, 2002-01, Vol.62 (4), p.333-339

2002

Volltextzugriff (PDF)

Continuous versus bilevel positive airway pressure in a patient with idiopathic central sleep apnea

American journal of respiratory and critical care medicine, 1997-04, Vol.155 (4), p.1482-1485

1997

Volltextzugriff (PDF)

Prognostic Significance of p27KIP1 Protein and Ki-67 Growth Fraction in Non-small Cell Lung Cancers

Clinical cancer research, 2000-10, Vol.6 (10), p.4073-4081

2000

Volltextzugriff (PDF)

Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers

British journal of cancer, 1999-10, Vol.81 (4), p.696-701

1999

Volltextzugriff (PDF)

Predictive value of expression of p16 super(INK4A), retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers

British journal of cancer, 1999-10, Vol.81 (4), p.696-701

1999

Volltextzugriff (PDF)

Prognostic significance of p27/KIP1 protein (p27) and Ki-67 growth fraction in non-small cell lung cancers (NSCLCs)

Lung cancer (Amsterdam, Netherlands), 2000-09, Vol.29 (1), p.183-183

2000

Volltextzugriff (PDF)

Pulmonary infiltration with eosinophilia due to rabbit-fur antigen: diagnosis by allergen inhalation test

Nihon Kyōbu Shikkan Gakkai zasshi, 1997-04, Vol.35 (4), p.455

1997

Volltextzugriff (PDF)

Altered p16 super(INK4) and retinoblastoma protein status in non-small cell lung cancer: Potential synergistic effect with altered p53 protein on proliferative activity

Cancer research (Chicago, Ill.), 1996-12, Vol.56 (24), p.5557-5562

1996

Volltextzugriff (PDF)

Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer : Potential synergistic effect with altered p53 protein on proliferative activity

Cancer research (Chicago, Ill.), 1996-12, Vol.56 (24), p.5557-5562

1996

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(34)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(20)
Middle Aged
(18)
Male
(17)
Biological And Medical Sciences
(16)
Life Sciences & Biomedicine
(16)
Medical Sciences
(16)
Science & Technology
(16)
Female
(14)
Aged
(11)
Pneumology
(10)
Tumors Of The Respiratory System And Mediastinum
(10)
Lung Neoplasms - Pathology
(9)
Oncology
(9)
Adult
(8)
Carcinoma, Non-Small-Cell Lung - Pathology
(8)
Prognosis
(8)
Immunohistochemistry
(6)
Lung Neoplasms - Metabolism
(5)
Ophthalmology
(5)
Carcinoma, Non-Small-Cell Lung - Metabolism
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21 : Different roles of G1 cyclins in cell proliferation and prognosis

CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non‐small cell lung cancers

Prognostic factors for non-small cell lung cancer patients with driver mutation negative and brain metastases (HOT 1701)

1579P - Prognostic factors for non-small cell lung cancer patients with driver mutation negative and brain metastases (HOT 1701)

1579PPrognostic factors for non-small cell lung cancer patients with driver mutation negative and brain metastases (HOT 1701)

Direct instillation of the fibrin glue into the ruptured bulla is an effective treatment for uncontrolled pneumothorax occurred from severe emphysematous bullae

Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome

Predictive value of expression of p16 , retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers

Cyclin A Is a c-Jun Target Gene and Is Necessary for c-Jun-induced Anchorage-independent Growth in RAT1a Cells

Phase II Study of Amrubicin (AMR) for Patients with Non-Small Cell Lung Cancer (NSCLC) as Third-Line or Fourth-Line Chemotherapy: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901

Increased expression of β‐catenin predicts better prognosis in nonsmall cell lung carcinomas

HMG-I/Y Is a c-Jun/Activator Protein-1 Target Gene and Is Necessary for c-Jun–Induced Anchorage-Independent Growth in Rat1a Cells

Cyclin E Expression, a Potential Prognostic Marker for Non-Small Cell Lung Cancers

Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers

Randomized, phase II trial comparing amrubicin with topotecan in patients (pts) with previously treated small cell lung cancer (SCLC)

Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8 super(+) cytotoxic T lymphocytes and natural killer cells

RCAS1 Expression: A Potential Prognostic Marker for Adenocarcinomas of the Lung

Continuous versus bilevel positive airway pressure in a patient with idiopathic central sleep apnea

Prognostic Significance of p27KIP1 Protein and Ki-67 Growth Fraction in Non-small Cell Lung Cancers

Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers

Predictive value of expression of p16 super(INK4A), retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers

Prognostic significance of p27/KIP1 protein (p27) and Ki-67 growth fraction in non-small cell lung cancers (NSCLCs)

Pulmonary infiltration with eosinophilia due to rabbit-fur antigen: diagnosis by allergen inhalation test

Altered p16 super(INK4) and retinoblastoma protein status in non-small cell lung cancer: Potential synergistic effect with altered p53 protein on proliferative activity

Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer : Potential synergistic effect with altered p53 protein on proliferative activity

Suchergebnisse filtern